Inside an Arizona nursery caring for drug-dependent babies
Send a link to a friend
[April 21, 2023]
By Liliana Salgado
PHOENIX, Arizona (Reuters) - A nursery in Phoenix, Arizona, is treating
some of the most vulnerable victims of the long-running U.S. opioid
crisis: newborn babies.
The facility treats babies with neonatal abstinence syndrome (NAS), a
condition similar to withdrawal that develops when babies essentially
become addicted to drugs their mothers use during pregnancy. Babies with
NAS can tremble uncontrollably, clenching their muscles and gasping for
breath.
"When you see a baby withdraw you never, ever, ever forget it," Tara
Sundem, the executive director of Hushabye Nursery, told Reuters.
Newborns with NAS tend to crave the darkness and calm of the womb, so at
Hushabye the rooms are kept intentionally dark, sheltered from bright
light and commotion.
The nursery consists of 12 private rooms with a bed for parents to sleep
in as the child undergoes the detox process and a special bassinet that
helps calm them. While at a hospital it is not unusual for babies with
NAS to stay 21 days, at Hushabye eight days is the usual. The detox
nursery can treat the entire family under one roof and with one-on-one
support from caregivers.
"If I didn't meet Hushabye I would have had no clue what NAS was," said
Clarissa Collins, who went through the program with her newborn baby
daughter. "What to look for, how to care for my baby, I had no
knowledge." Collins now helps others facing the same battle and works as
a peer support specialist at the clinic.
[to top of second column]
|
Tara Sundem, executive director of
Hushabye Nursery, sits inside a nursery room where drug-dependent
babies undergo detox in Phoenix, Arizona, U.S. March 9, 2023.
REUTERS/Liliana Salgado
According to data compiled by the
Centers for Disease Control and Prevention, the number of babies
born with NAS increased 82% nationally from 2010 to 2017. In 2020,
around six newborns were diagnosed with NAS for every 1,000 hospital
stays.
Opioid-related deaths among Americans soared during the pandemic,
including from the powerful synthetic painkiller fentanyl,
exacerbating an already tragic and costly nationwide crisis.
Overdoses involving synthetic opioids, primarily fentanyl, killed
more than 70,000 people in the U.S. in 2021, according to the CDC.
(Reporting by Liliana Salgado, Editing by Rosalba O'Brien)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|